Immunological test and diagnostic kit for prostate adenocarcinoma
US7517653B2 · kind B2 · utility
0Cited by
0References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 12, 2001 |
| Grant date | Apr 14, 2009 |
| Priority date | — |
| Expiry date | Feb 8, 2022 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/57434
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
This invention concerns a test method for the purposes of diagnosis, prognosis or therapeutic monitoring in male patients with adenocarcinoma of the prostate or benign prostatic hyperplasia, which does not require a biopsy of prostate tissue, and which exploits the combination of at least one tissue-specific marker and at least one marker for inflammation in order to arrive at a diagnosis.The invention also concerns a process using such a method, an immunological test to implement such a process, and a diagnostic kit.The invention is applied to the diagnosis of adenocarcinoma of the prostate and benign prostatic hyperplasia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.